Search Results: TBIO (Biological and Medical Science) (5)
-
Date: 7 August 2020
Subject: Substandard/Falsified medical devices and personal protective equipment (PPE) used in the context of the COVID-19 pandemic
WHO-identifier: 2020/3, version 1
Type of action: Advice to users of medical devices and PPE used for prevention, treatment and care for COVID-19.<
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Climate and Environment, Coronavirus (COVID-19), Energy, Global Health
-
Schoolboy Yangyang was growing weaker by the day. When his symptoms worsened into diarrhoea and abdominal pain, his parents took him to the nearest hospital in Guangxi, southeastern China, where the doctor examined him on arrival and administered treatment. To confirm his suspicion, the doctor ordered a fecal examination. The result confirmed that Yangyang was suffering from a parasitic infection of the liver that can be caused by eating raw fish – a traditional dietary practice that has developed into a gr
Roles: Everyone: All Users
Regions: China, United Kingdom
Topics: Energy, Global Health, Science, Technology, and Innovation
-
Launching today, the COVID-19 Law Lab initiative gathers and shares legal documents from over 190 countries across the world to help states establish and implement strong legal frameworks to manage the pandemic. The goal is to ensure that laws protect the health and wellbeing of individuals and communities and that they adhere to international human rights standards.
The new Lab (at www.COVIDLawLab.org) is a joint project of United Nations D
Roles: Everyone: All Users
Regions: United Kingdom
Topics: Climate and Environment, Combating Drugs and Crime, Coronavirus (COVID-19), Economic Prosperity and Trade Policy, Global Health, Human Rights and Democracy, Science, Technology, and Innovation
-
Today, more than 20 leading biopharmaceutical companies are announcing the launch of the AMR Action Fund that will invest in developing innovative antibacterial treatments. The Fund aims to bring 2-4 new treatments to patients by 2030. This initiative is a significant step towards addressing the current crisis in antibacterial treatment development.